News from the FDA/CDC
News from the FDA/CDC
Prostate cancer drug shortage leaves some with uncertainty
The therapy lutetium Lu 177 vipivotide tetraxetan will remain in limited supply until the drug’s manufacturer can ramp up production.
News from the FDA/CDC
Cases of potentially deadly fungus jump 200%: CDC
People in hospitals and nursing homes are at a heightened risk because they might have weakened immune systems or be using invasive medical...
News from the FDA/CDC
HIV testing still suboptimal
“If we just look at the need for HIV testing based on who is at risk, I think that we are always going to fall short.”
News from the FDA/CDC
FDA moves to stop the spread of illicit ‘tranq’ in the U.S.
The agency “remains concerned about the increasing prevalence of xylazine mixed with illicit drugs,” said FDA Commissioner Robert M. Califf, MD....
News from the FDA/CDC
FDA strengthens mammography regulations: Final rule
A final rule requires that mammography facilities notify patients about the density of their breasts.
News from the FDA/CDC
FDA expands abemaciclib use in high-risk early breast cancer
The new expansion removes the Ki-67 testing requirement.
News from the FDA/CDC
FDA approves first biologic treatment for polymyalgia rheumatica
The interleukin-6 receptor antagonist sarilumab (Kevzara) will be indicated in adults who have had an inadequate response to corticosteroids or...
News from the FDA/CDC
Drug-resistant stomach bug infections on the rise: CDC
Most infections have been seen in men who have sex with men, but a small number have also occurred in women and in young children.
News from the FDA/CDC
FDA broadens warning on potentially contaminated eye products
An announcement released Wednesday adds to a...
News from the FDA/CDC
FDA puts hold on esophagitis, H. pylori drug, owing to impurity concerns
The manufacturer was asked to provide “additional stability data to demonstrate that levels of the impurity previously found in vonoprazan drug...
News from the FDA/CDC
New challenge for docs: End of COVID federal public health emergency
The Biden administration intends to end by May 11 certain COVID-19 emergency measures used to aid in the response to the pandemic.